HHMI's Thomas M. Jessell:

**Curis helping to treat cancer, neurological degenerative, kidney disorders, CUDC-101. Pathways, hedgehog, EGFR, Her2, Hsp90, Bcr-Abl/Src, CDK, BCL, MEK, VEGF, HDAC.**

Reply to topic
HHMI's Thomas M. Jessell:
hedgehog
Site Admin

Joined: 19 Jan 2006
Posts: 820
Location: Bay Area
Reply with quote
September/October 1998
High Concentration on Cell Differentiation

One of the salient lessons to come out of developmental biology over the last two decades is that the mechanisms that control invertebrate development are conserved to an extraordinary extent, from fruit flies to humans. This lesson was put to the test in 1992 when researchers from Harvard, Columbia, Johns Hopkins, the University of California at San Francisco, and Oxford set out to find the mammalian equivalents of the hedgehog gene known to play an important role in pattern formation in the developing fruit fly. The result, within the course of a year, was the discovery of three new mammalian genes—known as sonic, indian, and desert hedgehog—and the realization that the proteins they coded for could account for a significant fraction of all the developmental interactions known to occur in the vertebrate embryo.

"The hedgehog protein provides a striking case in which a complex group of neurons that eventually function together are all induced by the same signaling molecule, just by its acting at different concentrations," says Thomas M. Jessell of the Howard Hughes Medical Institute. "It’s a very economical way of generating cell diversity."

Among the major players in this developmental watershed was Thomas M. Jessell, a Howard Hughes Medical Institute investigator at Columbia University College of Physicians and Surgeons, New York, whose work helped elucidate the role sonic hedgehog plays in the development and differentiation of the spinal cord and nervous system. Jessell's remarkable influence in developmental biology is evidenced by a steady and methodical production of high-impact papers, including two dozen in the past decade with over 100 citations each, and six that have each been cited over 300 times. Along with Andrew MacMahon, Douglas A. Melton, and Cliff Tabin of Harvard, Jessell is also one of the founders of Ontogeny, Inc., a high-profile Cambridge, Massachusetts, biotech company that aims at using the approaches of developmental biology to come up with new treatments for diseases ranging from diabetes to Parkinson's. Jessell, 47, received his undergraduate education at the University of London, and went on to get a master's at London Hospital. In 1977, he earned his Ph.D. in neuropharmacology from Cambridge University and in 1981, after three years of fellowships, became an assistant professor of neurobiology at Harvard Medical School. In 1985 Jessell moved to Columbia University College of Physicians and Surgeons, where he also became an Investigator at the Howard Hughes Medical Institute. Since 1989, Jessell has been professor in the Department of Biochemistry and Molecular Biophysics, at the Center for Neurobiology and Behavior at Columbia. From his office at Columbia, Jessell spoke to Science Watch correspondent Gary Taubes.

: How would you describe the overall aim of your laboratory?

Jessell: Our interest is in understanding how the nervous system functions—specifically, how different cell types in the nervous system actually become different. One basic problem is simply identifying these different cell types. At the very early stages of development, it’s impossible to recognize a motor neuron or a sensory neuron by their characteristic adult appearance. So we need to have an independent method of distinguishing different classes of cells. This is where transcription factor biology becomes very important, since the major molecular distinctions that exist between different classes of neurons can be recognized by their different expression of specific sets of transcription factors. So we can generate, for example, antibodies against these proteins. Then, at very early stages of development—just as the earliest precursor of the nervous system, the neural plate, is beginning to form the neural tube and the spinal cord—we can start to recognize molecular differences between different cell types. That is a key step in even defining an assay to identify the factors that control these distinctions in cell identity.

: Can you explain what you mean by transcription factor biology?

Jessell: The whole problem of developmental biology is how to turn specific sets of genes on in specific cell types. The way to activate gene expression is through transcription factors—the proteins that bind DNA and then lead to activation of target genes. Over the last decade, from thousands of different labs, there has been an explosion of information on different classes of transcription factors. A breakthrough from our point of view was the observation than when one cell expresses a particular protein and its neighbor doesn't, it gives you a molecular handle to ask questions about how a given pattern of cell types is generated. We’ve spent a lot of time mapping the early expression of different classes of transcription factor. In particular, we’ve been focusing on the spinal cord, and we can now do a rather good job of accounting for each of the developmental stages, proceeding from a uniform group of precursor cells in the neural plate, where all the cells are the same, to the point halfway through nervous-system development where you have 20 different cell types.

: How do you find out when those transcription factors are turned on and exactly what they do?

Jessell: One type of experiment, for instance, is to take a piece of neural tissue at a time before it's been exposed to any environmental factors. You then examine the fate of those cells under that default program, so to speak. The next step is to add a potential source of an inductive signal and show that the program is changed—the cells become something else. That extrinsic signal might turn out to be, for example, hedgehog. An extrinsic signal is a protein that is excreted by one cell and which influences or changes the fate of a neighboring cell. That's a process of cell-cell communication. It changes the cell’s fate by turning one transcription factor on and turning another one off. This experimental method uses transcription factors as sort of molecular beacons to assay the existence of a diffusible or a cell-cell signal.

: The big breakthrough in your field was the discovery of the hedgehog genes in mammals. How has that work been developed?

Jessell: It turns out that there are three hedgehog genes in higher vertebrates, in mammals. Different groups cloned different hedgehogs early on. They're all interesting, but the one that is the most interesting to us is a gene that Cliff Tabin at Harvard eventually named sonic hedgehog. It turns out to be expressed in precisely those cells in the limb bud that have the limb-patterning activity. And it turns out to be expressed in just those cells under the spinal cord, in the notochord and later in the floorplate, that have the spinal-cord-patterning activity, which is what we were looking for. By now, many papers have established the function and the necessity of hedgehog in these signaling processes. In the context of the spinal cord, one of the surprising things to emerge is that, at least in the ventral half of the spinal cord, which generates many different cell types, hedgehog is responsible for the generation of each of those cell types. It does this by acting at different concentration thresholds to establish different cell fates.

: Different concentration thresholds?

Jessell: There is now evidence that two-fold differences in the concentration of sonic hedgehog proteins to which a cell is exposed produce very dramatic changes in the eventual fate of that cell. So we can do in vitro assays where we can essentially dial in the concentration of hedgehog and generate a predictable cell type at each concentration. There are many precedents for this, both in Drosophila and in vertebrate development. The hedgehog example, however, provides a particularly striking case, where a complex group of neurons that eventually function together—motor neurons and different types of interneurons—are all induced by the same signaling molecule, just by its acting at different concentrations. It’s a very economical way of generating cell diversity from one signaling molecule.

http://www.hhmi.org/jessell/jessell_isi/
View user's profileSend private messageSend e-mailMSN Messenger
HHMI's Thomas M. Jessell:
All times are GMT - 7 Hours  
Page 1 of 1  

  
  
 Reply to topic  
Forum Map
Site Map